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1. Introduction 
In 1965 Chappell and Crofts [I] concluded that 
there exist anion translocators in inner mitochondrial 
membranes. glutamate having a specific one. To our 
knowledge no such anion translocator has been iso- 
lated up to now and their true nature and mechanism 
of action remain unknown. Nobody knows as yet if 
the main glutamate oxidizing enzymes, GDH* and 
AAT, play a role in its translocation through the inner 
membrane. Both enzymes are located in the inner 
membrane-matrix compartment and it has been shown 
that GDH exists in two different forms [2] one of 
which is tightly bound to the inner membrane. The 
role of this membrane-bound GDH is not yet under- 
stood but the great affinity of GDH for membrane car- 
diolipin can account for its tight binding [3-S]. 
Besides we have shown [6] that AAT coupled on 
both sides of an artificial membrane of collagen [7] 
stimulates glutamate diffusion across the membrane. 
In the present paper we report the isolation proce- 
dure for HGAP, a very insoluble proteolipid extracted 
*Abbreviations used: HGAP, high glutamate affinity proteo- 
lipid; GDH, glutamate dehydrogenase (EC 1.4.1.3); 
AAT, aspartate aminotransferase (EC 2.6.1.1); NEM, n-ethyl 
maleimide; CCCP, m-chlorocarbonyl cyanide phenylhydra- 
zone. 
? Preliminary results were the subject of a communication at 
the 8th FEBS Meeting, 1972 [6] and at the XI Jornadas 
Bioquimicas Latinas, 1973, Salamanca. 
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from pig-heart mitochondria which exhibits all the 
properties expected from a glutamate translocator 
while it presents neither GDH nor AAT activities. 
2. Materials and methods 
Pig-heart mitochondria were prepared in 0.25 M 
sucrose, 10 mM Tris-HCl, pH 7.4, according to the 
method of Crane et al. [8] modified as previously re- 
ported [9]. 
Fig. 1 describes the purification scheme of HGAP 
starting from frozen mitochondria; the first steps 
(part 1) lead to the PA pellet which exhibits neither 
GDH nor AAT activity. P, is dissolved in 2% cholate 
and treated by affinity-batch separation (part 2) on 
human serum albumin reticulated on glass fibre and 
loaded with glutamate or with the y-methylester of 
glutamate to separate proteins exhibiting glutamate 
affinity. This system was prepared as follows: 84 ml 
of 10 mM phosphate (K+), pH 7.0, 34 g finely divided 
Pyrex glass fibre, 2.5 ml human serum albumin (22%), 
3.2 ml of 25% glutaraldehyde, are well homogenized 
at -30°C; the frozen cake is kept overnight at -3O”C, 
then thawed, manually divided and washed at room 
temperature with 10 mM phosphate (K+), pH 7.0. The 
residue is incubated 24 hr in the same phosphate buff- 
er with 50 mM glutamate or the y-methylester of glu- 
tamate and 3% glutaraldehyde, then extensively 
washed successively in phosphate buffer, phosphate 
buffer t 2% cholate, phosphate buffer t 2% cholate + 
M KCI. The final residue, after equilibration with 
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Fig. 1. PB*: 10 mM phosphate (K+), 1 mM 2-mercaptoethanol, pH 7.2. For procedure see Materials and methods. 
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Fig. 2. High affinity binding of glutamate by HGAP. Gluta- 
mate concentration range 2-500 FM. Equilibrium dialysis: 
18 hr. 4”C, in 10 mM phosphate (K+) (Union Carbide Visking 
tubes, 24 A pores, 50 b thick). 1 mM 2-mercaptoethanol, 
pH = 7.2. (X) Control: material recovered on albumin alone; 
(0) HGAP. Insert - Saturation curve of HGAP by glutamate. 
Table 1 
Effects of NEM and Avenaciolide on glutamate binding by 
HGAP. 
+ Avena- 
Control ciolide + NEM 
Total cpm in excluded volume 600 400 125 
Percent residual binding 64 18 
Percent inhibition 36 82 
5 min incubation of 0.378 mg HGAP in 0.2 ml 0.25 M sucrose, 
IO mM Tris-acetate, 1 mM EDTA, pH 7.8, 28°C; when present: 
0.4 pmole NEM or 94 nmoles Avenaciolide per mg protein. 
Then 0.3 PCi [ 2, 3-3H]glutamate was added (final concn. 70 
mM). After 10 more minutes incubation, the mixture was 
passed through a 1 X 25 cm Sephadex G-SO (coarse) column. 
Counts were made on equal fractions of the excluded volume. 
Averages of two experiments. 
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Fig. 3. Sedimentation velocities of HGAP supernatant: 
(A-A-A) heavy peak; (b--a--n) light peak; (o--i-j---o) 
beef liver GDH (Boehringer, Mannheim); (*-o-o) 
HGAP + GDH. Centrifugation run in IO mM (K+) phosphate 
buffer, 1 mM 2-mercaptoethanol, pH = 7.2, 20°C. Rotor 
AND, Beckman analytical centrifuge model E. 
10 mM phosphate (K+), 1 mM 2-mercaptoethanol, 
2% cholate, pH 7.2, is ready for affinity-batch separa- 
tion. PA separates into two fractions absorbing at 
280 nm: F, is not retained by the batch; the M KC1 
required to elute F, indicates that F, is tightly re- 
tained by the glutamate or by the y-methylester of 
glutamate which strongly inhibits glutamate entry 
into brain tissue [lo] and into pig-heart mitochon- 
dria. If the separation is conducted on a column, F, 
gives a sharp peak which includes 86% of PA. Dialysis 
and centrifugation of F2 yield HGAP (pellet or solu- 
ble form). 
3. Results and discussion 
3.1. Physicochemical properties of HGAP 
3.1.1. Glutamate binding 
HGAP exhibits high affinity for glutamate which 
permits its purification. Fig. 2 shows that [14C]gluta- 
12 
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Fig. 4. Mitochondrial oxidation of glutamate and effect of 
HGAP. 1.15 mg/ml of pig-heart mitochondrial proteins were 
incubated in: 3 ml of 20 mM Tris-HCI, 125 mM KCI, pH = 
7-2, 28°C with CCCP (1.6 &mg) until complete oxidation 
of endogenous NAD(P). Then 0.16 fig/ml antimycin A (anti 
A) was added to prevent any reoxidation followed by 0.66 
mM 2-mercaptoethanol to both control or NEM inhibited as- 
says (0.4 pmoles NEM/mg protein). HGAP: 0.05 mg/ml i.e. 
43 pg/mg mitochondrial protein; if HGAP was added before 
2-mercaptoethanol to inhibited assays no release of inhibition 
occurred since HGAP reacts with NEM. 
T 
2 
f 
8 
; 
: 
1 
0 
mate binding gives a saturation curve (insert); the 
Scatchard plot reveals only high affinity sites: Kd = 
62 /.tM. 
Avenaciolide [ 1 l] and NEM [ 12,131, which in- 
hibit glutamate entry in mitochondria or in other tis- 
sues [lo] , prevent glutamate binding to HGAP (table 
1). 
3.1.2. Lipid composition 
HGAP is a proteolipid containing about 0.6 Ccmoles 
phospholipids/mg protein, i.e. 45% of the dry weight. 
The lipid moiety is made mainly of phosphatidyl choline, 
phosphatidyl ethanolamine and cardiolipin with traces 
of minor components. Lipid analysis was performed as 
described elsewhere [ 141. 
3.1.3. Molecular properties 
The characterization of the protein moiety is not 
easy owing to the strong tendency of HGAP to give 
very insoluble aggregates which are difficult to analyse 
by electrophoresis. Gel electrophoresis of HGAP on 
6% polyacrylamide according to Ray and Marinetti 
[ 151 gives two bands while a significant proportion 
of the material is excluded. The soluble form of 
HGAP (178 000 g supernatant, fig. 1) exhibits the 
same biological properties and gives two distinct 
peaks on analytical ultracentrifugation (fig. 3), a light 
I EXPERIMENTAL 
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4 I‘ ’ .-. .. 
I time I time- I 
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Fig. 5. Time-dependent inhibition of beef liver GDH activity by HGAP. Effect of ADP: 0.3 pg GDH was incubated with 0.16 mM 
NAD+ in 3 ml 10 mM phosphate (K+), 1 mM 2-mercaptoethanol, 0.5 mM EDTA, 28”C, with 3.33 pg HGAP/ml; 1.66 mM gluta- 
mate was added at time = 0; 0.033 mM ADP, a positive effector of GDH, was added either together with glutamate (0 time) or 
after a variable time. GDH activity is measured by the reduction of NAD+. 
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Fig. 6. Effects of HGAP on glutamate entry into liposomes 
containing GDH: A) fist procedure. Liposomes were pre- 
pared in 10 ml, 10 mM Tris-acetate, 1 mM EDTA, 0.25 M 
sucrose, 0.1 M ammonium sulfate, 0.25 M KCl, 1% Lubrol 
WX, pH 7.8, from 500 mg of pig-heart mitochondriaf lipids 
Folch extract [ 17) ; B) second procedure, identical, except 
that the lipids were sonicated at O”C, 5 min at maximal power 
(MSE disintegrator 60 W). Wizen in both cases 0.1 mg GDH/ml 
and 15 mM NAD+ were added. The mixture was dialysed 3 
days against 0.25 M sucrose, 10 mM Tris-acetate, 1 mM 
EDTA, pH 7.8 and finally spun down for 2 hr. Liposomes 
were the 178 000 g pellet. GDH activity was measured by fol- 
lowing NAD reduction in the same buffer as for the dialysis: 
Glutamate, 3.3 mM; NEM, 0.4 pmole/mg protein; Control: 
GDH, 0.3 ,ug; NAD+. 0.16 mM. Labelled glutamate incorpora- 
tion was conducted using the technique described in the leg- 
end to table 1. 
(Go,,= 2.0) and a heavy one exhibiting a disaggrega- 
tion phenomenon as shown by the variation of S$ w 
from 18 at the beginning of the run to 5.5, at the end, 
as the fraction is diluted; this soluble HGAP, concen- 
trated on an Amicon ultrafilter PM 30, yields insoluble 
HGAP pellets. 
Soluble HGAP and GDH give an homogeneous as- 
sociation with Sio w= 6.3 while GDH alone shows 
s;o,w= 13.1. 
3.1.4. Other properties 
HGAP exhibits great thermal susceptibility and 
should be frozen quickly in liquid nitrogen to retain 
its activity when stored at -20°C. 
3.2. Biological properties of HGAP 
3.2.1. Effects of HGAP on whole pig-heart mitochon- 
dria 
HGAP added to whole mitochondria stimulates 
glutamate entry (fig. 4) as measured by the endoge- 
nous NAD(P) reduction according to Chappell [ 161 
and partly restores glutamate entry in NEM-inhibited 
mitochondria. Fuscin [ 171 and avenaciolide [ 1 I] pro- 
duce atypical inhibition of glutamate entry in pig- 
heart mitochondria but HGAP restores state 3 respira- 
tory stimulation. 
3.2.2. Effects of HGAP on GDH 
Fig. 5 shows that HGAP strongly inhibits GDH ac- 
tivity while it does not affect malate dehydrogenase or 
AAT activities; the cardiolipin content of HGAP could 
account for this strong inhibition but the inhibition 
pattern is very different to that previously described 
with pure cardiolipin [3] ; here the inhibition increases 
during the time course of either glutamate oxidation 
or cY-ketoglutarate r duction, suggesting that HGAP 
acts as an irreversible inhibitor. ADP, a well-known ac- 
tivator of GDH prevents HGAP inhibition and partial- 
ly releases it. 
3.2.3. Effects of HGAP on liposomes 
Fig. 6 shows that liposomes made of crude pig- 
heart mitochondrial lipids (Folch’s extract [ 181) con- 
taining small amounts of GDH and NAD+, offer a 
good test for the translocating properties of HGAP. 
According to Chappell’s technique [ 161 if glutamate 
enters, intraliposomal NAD+ will be reduced. When 
the lipids were not sonicated (fig. 6A) GDH was dis- 
tributed mainly in the supernatant where the NAD+ 
reduction is inhibited by HGAP, as observed in the 
control (pure GDH + NAD+). On the contrary the ad- 
dition of HGAP to liposomes stimulates internal NAD+ 
reduction which proves firstly that some GDH is real- 
ly enclosed in the liposomes, otherwise HGAP would 
inhibit it and secondly that HGAP catalyses glutamate 
entry, otherwise, NAD would not be reduced; NEM 
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inhibits the entry as is observed with whole pig-heart 
mitochondria. In the second procedure (fig. 6B) 
where lipids are sonicated, no GDH activity could be 
detected either in the supernatant or in the pellet in 
the absence of HGAP; HGAP makes glutamate acces- 
sible to GDH inside the liposomes as shown by the 
NAD+ reduction, which proves that GDH cannot in- 
teract directly with HGAP. A further proof is that 
HGAP increases [3H]glutamate incorporation into 
liposomes by 50% indicating some external binding of 
glutamate; boiled liposomes show a low binding capac- 
ity and no HGAP effects. 
3.2.4. Apparent Km for glutamate entry into pig-heart 
mitochondria and K, of HGAF’ 
Glutamate entry into pig-heart mitochondria was 
measured using the method of Chappell [ 161 by fol- 
lowing the reduction of endogenous NAD+(P) either 
in the dual wavelengths (340-373 nm) or in the split 
beam mode (340 nm, two cuvettes) in 16 mM Tris- 
HCI, 112 mM KCI, 5 mM Pi (K+), CCCP (90 nmoles/ 
mg protein), Antimycin A (0.3 pg/mg protein), pH 7.4 
(3-4.8 mg protein/3 ml). Only mitochondria with res- 
piratory control ratios over 5 give reproducible results. 
Perfect Michaelis kinetics are obtained versus external 
glutamate; averages of 8 experiments give: approx. 
Km (glutamate entry): 76.6 + 15.4~.1M: this value is 
very close to the K, (62 PM) of glutamate binding to 
HGAP; approx. Pm, (glutamate entry): 0.29 + 0.02 
nmoles NADH/min/mg protein Standard error of the 
means calculated according to Wilkinson [ 191 by a 
computational procedure. 
4. Conclusions 
Starting from 726 mg pig-heart mitochondrial pro- 
tein (quick biuret method) 8.4 mg dry weight HGAP 
were obtained; because of the number of purification 
steps and the use of 2% cholate, this amount cannot 
reflect the true mitochondrial concentration of HGAP. 
HGAP exhibits all the properties expected for a 
glutamate translocator: it is a proteolipid very insolu- 
ble in water, this being an intrinsic property of mem- 
brane proteins; it contains large amounts of the phos- 
pholipids found in mitochondrial inner membranes es- 
pecially cardiolipin. This agrees with the inner mem- 
brane location of anion translocators [l] ; it binds glu- 
tamate with high affinity with a K, = 62 PM very 
close to the Km = 76.6 PM, for glutamate entry in 
wellcoupled pig-heart mitochondria. According to 
Oxender [20] this is what should be expected from 
a translocator; NEM and avenaciolide inhibit labelled 
glutamate binding to HGAP at concentrations which 
inhibit glutamate translocation into pig-heart mito- 
chondria; it restores glutamate translocation into 
mitochondria preinhibited by NEM, avenaciolide or 
fuscin; it provokes glutamate entry into liposomes 
made of pig-heart mitochondrial lipids; this HGAP-de- 
pendent glutamate entry is inhibited by NEM; it ex- 
hibited no enzymic properties towards glutamate 
(neither GDH, nor AAT activities); one can expect 
that a translocator does not consume the substrate it 
carries. 
However, the following experimental results may 
reflect the involvement of an inhibited form of GDH 
as well as of HGAP in the glutamate translocator: the 
association of GDH and HGAP (which contains cardio- 
lipin) inhibits GDH and gives a single peak on ultra- 
centrifugation; cardiolipin inhibits GDH with a strong 
affinity: Ki = 24 nM [ 3] ; GDH aggregates with cardio- 
lipin in specific conditions depending upon cardiolipin 
concentration, glutamate, coenzyme and nucleotide 
concentration [ 2 1 ] . 
As a concluding remark, if HGAP stimulation of 
glutamate entry into liposomes and pig-heart mito- 
chondria was only a general detergent-like effect, 
upon HGAF’ addition, NAD+ would leak out of both 
particles; NAD+ concentration would become lower 
and no GDH activity could be enhanced. Besides 
HGAP could inhibit GDH. However this does not ex- 
clude the possibility that HGAP provokes a rearrange- 
ment of lipid-protein interactions. 
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